Milestone Pharmaceuticals Inc.
MIST · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $1 |
| Gross Profit | -$0 | $0 | $0 | -$1 |
| % Margin | – | – | – | – |
| R&D Expenses | $4 | $4 | $5 | $4 |
| G&A Expenses | $0 | $4 | $5 | $0 |
| SG&A Expenses | $8 | $9 | $16 | $8 |
| Sales & Mktg Exp. | $0 | $5 | $10 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $12 | $13 | $21 | $12 |
| Operating Income | -$12 | -$13 | -$21 | -$12 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$12 | -$13 | -$21 | -$12 |
| Tax Expense | -$0 | $0 | $0 | -$0 |
| Net Income | -$12 | -$13 | -$21 | -$12 |
| % Margin | – | – | – | – |
| EPS | -0.12 | -0.2 | -0.31 | -0.2 |
| % Growth | 40% | 35.5% | -55% | – |
| EPS Diluted | -0.12 | -0.2 | -0.31 | -0.2 |
| Weighted Avg Shares Out | 66 | 66 | 66 | 62 |
| Weighted Avg Shares Out Dil | 66 | 66 | 66 | 62 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $1 | $1 |
| Interest Expense | $1 | $1 | $1 | $1 |
| Depreciation & Amortization | $0 | $0 | $0 | $1 |
| EBITDA | -$11 | -$12 | -$20 | -$11 |
| % Margin | – | – | – | – |